Search - tctmd.com

Displaying 1 - 20 of 57

Sort: Relevancy | Date

News Conference News AHA 2025

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Michael O'Riordan

November 08, 2025

News Daily News

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

L.A. McKeown

September 22, 2025

News Daily News

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Michael O'Riordan

June 04, 2025

News Conference News AHA 2024

Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

Caitlin E. Cox

November 21, 2024

News Daily News

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

L.A. McKeown

June 18, 2024

News

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Michael O'Riordan

May 30, 2024

News Conference News ACC 2024

Need a Statin for Primary Prevention? There’s an App for That

Michael O'Riordan

April 10, 2024

News Opinion CV Team Dispatch

March 2024 Dispatch for the CV Team

L.A. McKeown

March 01, 2024

News Daily News

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Michael O'Riordan

February 27, 2024

News Daily News

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

Yael L. Maxwell

February 15, 2024

News Daily News

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

Caitlin E. Cox

December 06, 2023

News Daily News

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

Todd Neale

November 22, 2023

News Conference News EACTS 2023

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Michael O'Riordan

October 05, 2023

News Daily News

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

Michael O'Riordan

July 25, 2023

News Conference News AHA 2022

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Michael O'Riordan

November 06, 2022

News Daily News

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Michael O'Riordan

August 11, 2022

News Daily News

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

Todd Neale

July 20, 2022

News Daily News

High Lp(a) May Predict Risk of CV and Limb Events in PAD

L.A. McKeown

July 18, 2022

News Daily News

Good News and Bad for High-Intensity Statin Use in ASCVD

Michael O'Riordan

May 05, 2022

News Conference News ESC 2021

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Michael O'Riordan

September 02, 2021

Advertisement

Evolocumab Cuts MACE Risk in Patients Without Prior MI, Stroke: VESALIUS-CV

Good LDL Control When PCSK9 Inhibitors Given In-Hospital After Interventions

Inclisiran Plus Usual Care Improves LDL Control in ACS: VICTORION-INCEPTION

Clues to Evolocumab Response Exist in Patients’ Genes: YELLOW III

Dramatic LDL Drops Seen in PAD Patients With Team-Based Care

Two siRNA Therapeutics Safely Lower Triglycerides in Mixed Hyperlipidemia

Need a Statin for Primary Prevention? There’s an App for That

March 2024 Dispatch for the CV Team

High Lp(a) Levels Harmful in Patients With and Without ASCVD

Increased Lp(a) Ups CV Risk Regardless of hs-CRP Level

PAD, AAA: High Lp(a) Portends Problems Beyond CVD

Turning Back Subclinical Atherosclerosis Possible in Some Middle-Age People

SWEDEHEART Hints at Mortality Benefit With Statins After SAVR

Pitavastatin Cuts MACE in HIV-Infected Patients: REPRIEVE

‘Dramatic’ Reductions in Lp(a) With Olpasiran: OCEAN(a)-DOSE

Genetic Study Hints at Cognitive Impact of Statins, but Experts Urge Caution

Ezetimibe Plus Moderate Statin a Welcome Alternative for High-Dose Monotherapy

High Lp(a) May Predict Risk of CV and Limb Events in PAD

Good News and Bad for High-Intensity Statin Use in ASCVD

No Attenuation in CVD Risk Reduction for Patients Treated to Very Low LDLs: FOURIER

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content